Diarylamine-based fluorogenic probes for detection of peroxynitrite

US9651528B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9651528-B2
Application numberUS-201313754499-A
CountryUS
Kind codeB2
Filing dateJan 30, 2013
Priority dateJan 30, 2012
Publication dateMay 16, 2017
Grant dateMay 16, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are improved fluorogenic compounds and probes that can be used as reagents for measuring, detecting and/or screening peroxynitrite. The fluorogenic compounds of the invention can produce fluorescence colors, such as green, yellow, red, or far-red. Also provided herein are fluorogenic compounds for selectively staining peroxynitrite in the mitochondria of living cells. Provided also herein are methods that can be used to measure, directly or indirectly, the presence and/or amount of peroxynitrite in chemical samples and biological samples such as cells and tissues in living organisms. Also provided are high-throughput screening methods for detecting or screening peroxynitrite or compounds that can increase or decrease the level of peroxynitrite in chemical and biological samples.

First claim

Opening claim text (preview).

We claim: 1. A compound of formula (I) or (II): or a tautomer thereof; wherein N is a nitrogen atom, and is linked to Q and R 1 through single covalent bonds; R 1 is H, alkyl, halogenated alkyl, alkenyl, alkynyl, alkoxyalkyl, heteroalkyl, cycloalkyl, cycloalkenyl, cycloalkynyl, heterocyclyl, aminoalkyl, arylalkyl, alkyloxy, carboxyalkyl, alkylamino, alkoxyamino, alkylamido, alkoxyamido, or acyl; each of R 2 , R 3 , R 4 , R 5 , R 6 and R 7 is independently H, F, Br, I, CN, alkyl, halogenated alkyl, heteroalkyl, alkenyl, alkynyl, aralkyl, aryl, alkaryl, heterocyclyl, cycloalkyl, cycloalkenyl, cycloalkynyl, hydroxyalkyl, aminoalkyl, amino, alkylamino, arylamino, dialkylamino, alkylarylamino, diarylamino, acylamino, hydroxy, thiol, thioalkyl, alkoxy, alkylthio, alkoxyalkyl, aryloxy, arylalkoxy, acyloxy, nitro, carbamoyl, trifluoromethyl, phenoxy, benzyloxy, phosphonic acid, phosphate ester, sulfonic acid (—SO 3 H), sulfonate ester, sulfonamide, —C(═O)—P 1 or —C(═O)-M-P 2 ; each of P 1 and P 2 is independently hydrogen, halo, alkoxy, hydroxy, thiol, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkaryl, arylalkyl, carbamate, amino, alkylamino, arylamino, dialkylamino, alkylarylamino, diarylamino, alkylthio, heteroalkyl, alkyltriphenylphosphonium, or heterocyclyl having from 3 to 7 ring atoms; M is alkylene, alkenylene, alkynylene, arylene, aralkylene or alkarylene; A is NR 11 R 12 and B is N + R 11 R 12 with a biologically compatible counterion selected from chloride, bromide, iodide, sulfate, alkanesulfonate, arylsulfonate, phosphate, perchlorate, tetrafluoroborate, tetraphenylboride, nitrate and anions of aromatic or aliphatic carboxylic acids; wherein: R 11 in combination with R 4 or R 12 in combination with R 3 , but not both, forms a 5- or 6-membered ring that is saturated or unsaturated, or further fused with an aryl or heteroaryl ring, and is optionally substituted by one or more alkyls, carboxylic acids, sulfonic acids (—SO 3 H), or their salts, ester or amide derivatives the other of R 11 or R 12 is H, alkyl, halogenated alkyl, alkenyl, alkynyl, alkoxyalkyl, heteroalkyl, cycloalkyl, cycloalkenyl, cycloalkynyl, heterocyclyl, aminoalkyl, arylalkyl, alkyloxy, acyl, carboxyalkyl, sulfoalkyl, a salt of carboxyalkyl, a salt of sulfoalkyl, or an ester or amide of carboxyalkyl or sulfoalkyl; or R 11 in combination with R 12 forms a piperazine, which is optionally substituted by alkyl, carboxylic acid, a salt of carboxylic acid, or a carboxylic acid ester of an alcohol; Z is O; R 8 has the formula wherein each of R 17 , R 18 , R 19 , R 20 and R 21 is independently H, F, Cl, Br, I, CN, nitro, a carboxylic acid, a salt of carboxylic acid, sulfonate ester (—SO 3 R 15 ), hydroxy, azide, alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkylaryl, arylalkyl, heterocyclyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, acyl, alkylcarbonylalkyl, halogenated alkylcarbonylalkyl, trifluoromethylcarbonylalkyl, aminoalkyl, carboxyalkyl, thiol, alkylthio, amino, alkylamino, dialkylamino, alkoxycarbonyl, alkoxycarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, or arylcarboxamido, the alkyl or aryl of which is optionally substituted by one or more F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, a carboxylic acid ester of an alcohol, amino, alkylamino, dialkylamino, alkoxy, alkyltriphenylphosphonium, sulfonic acid (—SO 3 H), sulfonate ester (—SO 3 R 15 ), or sulfonamide (—SO 2 NR 15 R 16 ) or R 17 and R 18 together, R 18 and R 19 together, R 19 and R 20 together, or R 20 and R 21 together form a 5- or 6-membered cycloalkyl, heterocyclyl, aryl or heteroaryl ring fused with the phenyl ring of formula (III) that is optionally further substituted by one or more F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, a carboxylic acid ester of an alcohol, amino, alkylamino, dialkylamino, alkoxy, thiol, alkylthio, alkyltriphenylphosphonium, sulfonic acid (—SO 3 H), sulfonate ester (—SO 3 R 15 ), or sulfonamide (—SO 2 NR 15 R 16 ), and wherein at least one of R 17 , R 18 , R 19 , R 20 and R 21 is not H or alkyl, wherein each of R 15 and R 16 represents a saturated or unsaturated, cyclic or acyclic alkyl that is optionally substituted by one or more F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, a carboxylic acid ester of an alcohol, amino, alkylamino, dialkylamino, alkoxy, or alkyltriphenylphosphonium; R 9 is H, hydroxy, CN or alkoxy; or R 9 in combination with R 17 or R 21 forms a 5- or 6-membered spirolactone, spirosultone, spirolactam or spirosultam ring that is optionally and independently substituted by H, F or CH 3 ; and Q is a substituted phenyl represented by formula (IV): wherein each of R 22 , R 23 , R 24 , R 25 , and R 26 is independently H, hydroxy, alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkylaryl, arylalkyl, heterocyclyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, acyl, alkylcarbonylalkyl, halogenated alkylcarbonylalkyl, trifluoromethylcarbonylalkyl, aminoalkyl, carboxyalkyl, thiol, alkylthio, amino, alkylamino, dialkylamino, alkoxycarbonyl, alkoxycarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, or arylcarboxamido, wherein at least one of R 22 , R 23 , R 24 , R 25 , and R 26 is not H, wherein any of the alkyl or aryl of which is optionally substituted by one or more F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, a carboxylic acid ester of an alcohol, amino, alkylamino, dialkylamino, alkoxy, alkyltriphenylphosphonium, sulfonic acid (—SO 3 H), sulfonate ester (—SO 3 R 15 ), or sulfonamide (—SO 2 NR 15 R 16 ); or wherein R 22 and R 23 together, R 23 and R 24 together, R 24 and R 25 together, or R 25 and R 26 together form a 5- or 6-membered cycloalkyl, heterocyclyl, aryl or heteroaryl ring fused with the phenyl ring of formula (IV) that is optionally further substituted by one or more F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, a carboxylic acid ester of an alcohol, amino, alkylamino, dialkylamino, alkoxy, thiol, alkylthio, alkyltriphenylphosphonium, sulfonic acid (—SO 3 H), sulfonate ester (—SO 3 R 15 ), or sulfonamide (—SO 2 NR 15 R 16 ) and the remainder of R 22 , R 23 , R 24 , R 25 , and R 26 are as previously defined; or wherein one of R 22 , R 24 , or R 26 is OR 27 , CH 2 CH 2 COR 28 , or NR 29 R 30 ; wherein R 27 is hydrogen or a group selected from alkyl, alkoxyalkyl, alkanoyl, and polyether; R 28 is an electron-withdrawing group selected from halogen-substituted lower alkyl, or (C═O)—O—W 1 , wherein W 1 is a group selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkaryl or arylalkyl, R 29 and R 30 are independently hydrogen, alkyl, alkenyl, alkynyl, alkoxyalkyl, alkanoyl, alkenoyl, alkynoyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkaryl, arylalkyl, aryloyl, or polyether and the remainder of R 22 , R 23 , R 24 , R 25 , and R 26 are as previously defined. 2. The compound of claim 1 , wherein the compound has one of formulae 11-19: 3. A compound of formula (I) or (II): or a tautomer thereof; w

Assignees

Inventors

Classifications

  • involving inorganic compounds or pH · CPC title

  • Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title

  • Spiro-condensed systems · CPC title

  • the oxygen-containing ring being six-membered · CPC title

  • Dyes containing a substituent, which contains a silicium atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9651528B2 cover?
Provided herein are improved fluorogenic compounds and probes that can be used as reagents for measuring, detecting and/or screening peroxynitrite. The fluorogenic compounds of the invention can produce fluorescence colors, such as green, yellow, red, or far-red. Also provided herein are fluorogenic compounds for selectively staining peroxynitrite in the mitochondria of living cells. Provided a…
Who is the assignee on this patent?
Univ Hong Kong
What technology area does this patent fall under?
Primary CPC classification G01N31/227. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).